Quality of Life Research

, Volume 17, Issue 3, pp 485–495 | Cite as

Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders

  • Joern MoockEmail author
  • Thomas Kohlmann



To compare the EQ-5D, 15D, HUI 2, HUI 3, SF-6D, and QWB-SA in terms of their descriptive statistics, score distribution, agreement and responsiveness in a sample of German rehabilitation inpatients.


Patients with musculoskeletal (N = 106), cardiovascular (N = 88), and psychosomatic (N = 70) disorders completed questionnaires at the beginning (baseline) and end (follow-up) of their inpatient treatment. Comparisons addressed the proportion of missing data, distributional properties, agreement, and responsiveness. Intraclass correlation coefficients (ICC), paired t-tests, and standardized response means (SRM) were computed.


Mean index scores at baseline ranged from 0.48 (HUI 3; psychosomatic) to 0.86 (15D; cardiovascular). At baseline, ceiling effects across all patient groups ranged from zero (SF-6D; cardiovascular and psychosomatic) to 21.6% (EQ-5D; cardiovascular). ICCs ranged from 0.26 (EQ-5D–QWB-SA; cardiovascular) to 0.80 (HUI 2–HUI 3; musculoskeletal). Substantial differences in responsiveness were observed between measures.


Results obtained with different preference-based quality-of-life measures in a sample of patients with mild to moderate disease severity are not equivalent. As differences between measures may have considerable effects in health economic evaluation studies, careful selection of instruments for a given study is essential.


Preference-based HRQoL Head-to-head comparison EQ-5D HUI 2 HUI 3 SF-6D 15D QWB-SA 



Our thanks go to HUI Inc. and John Horsman for permitting this project and to John Brazier for providing the SF-6D weights and Harri Sintonen for providing the 15D weights. We would also like to thank our cooperation partners Dr Klaus Drüner and Dr Detlev Besch and their colleagues at the rehabilitation clinic Göhren/Germany, and Dr Martin Grunze and Dr Helmhold Seidlein of the rehabilitation clinic Trassenheide/Germany. Further thanks go to Kathrin Bezold for her assistance with data collection. We gratefully acknowledge the constructive comments and suggestions received from John Brazier and the anonymous referees. This project was funded by a grant (no. 01GD0106) from the German Federal Ministry of Education and Research within the North German Network for Rehabilitation Research (NVRF).


  1. 1.
    Drummond, M. F., O’Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for economic evaluation of health care programmes (2nd ed.). Oxford, UK: Oxford University Press.Google Scholar
  2. 2.
    Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. Oxford, UK: Oxford University Press.Google Scholar
  3. 3.
    Coons, S. J., Rao, S., Keininger, D. L., & Hays, R. D. (2000). A comparative review of generic quality-of-life instruments. Pharmacoeconomics, 17(1), 13–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Kopec, J. A., & Willison, K. D. (2003). A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology, 56(4), 317–325.PubMedCrossRefGoogle Scholar
  5. 5.
    Brazier, J., Ratcliffe, J., Tsuchiya, A., & Salomon, J. (2007). Measuring and valuing health benefits for economic evaluation (1st ed.). Oxford, UK: Oxford University Press.Google Scholar
  6. 6.
    Green, C., Brazier, J., & Deverill, M. (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151–165.PubMedCrossRefGoogle Scholar
  7. 7.
    Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs. Health Services Research, 7(2), 118–133.PubMedGoogle Scholar
  8. 8.
    Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences—I: Measurement strategies. Journal of Clinical Epidemiology, 42, 345–354.PubMedCrossRefGoogle Scholar
  9. 9.
    The EuroQol Group (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.Google Scholar
  10. 10.
    Szende, A., Oppe, M., & Devlin, N. (2007). EQ-5d value sets: Inventory, comparative review and user guide. Kluwer Academic Publishers.Google Scholar
  11. 11.
    Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.PubMedCrossRefGoogle Scholar
  12. 12.
    Sintonen, H. (1994). The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. Working paper 41. Melbourne: National Centre for Health Program Evaluation.Google Scholar
  13. 13.
    Sintonen, H. (1995). The 15D measure of health related quality of life: Feasibility, reliability and validity of its valuation system. Working paper 42. Melbourne: National Centre for Health Program Evaluation.Google Scholar
  14. 14.
    Sintonen, H. (2001). The 15D instrument of health-related quality of life: properties and applications. Annals of Medicines, 33(5), 328–336.CrossRefGoogle Scholar
  15. 15.
    Brazier, J., Deverill, M., Green, C., Harper, R., & Booth, A. (1999). A review of the use of health status measures in economic evaluation. Health Technology Assessment, 3, 1–164.Google Scholar
  16. 16.
    Feeny, D. H., Torrance, G., & Furlong, W. J. (1996). Chapter 26: Health Utilities Index. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed., pp. 239–251). Philadelphia: Lippincott-Raven Publishers.Google Scholar
  17. 17.
    Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index (HUI®): Concepts, measurement, properties and applications. Health and Quality of Life Outcomes, 1(54).Google Scholar
  18. 18.
    Torrance, G. W., Feeny, D. H., Furlong, W. J., Barr, R. D., Zhang, Y., & Wang, Q. (1996). Multi-attribute preference functions for a comprehensive health status classification system: Health Utilities Index Mark 2. Medical Care, 34(7), 702–722.PubMedCrossRefGoogle Scholar
  19. 19.
    Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., Denton, M., & Boyle, M. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRefGoogle Scholar
  20. 20.
    Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRefGoogle Scholar
  21. 21.
    Kaplan, R. M., Sieber, W. J., & Ganiats, T. G. (1997). The Quality of Well-Being Scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychology & Health, 12, 783–791.CrossRefGoogle Scholar
  22. 22.
    Sieber, W. J., Groessl, E. J., David, K. D., Ganiats, T. G., & Kaplan, R. M. (2007). Quality of Well-Being Self-Administered (QWB-SA) scale. User’s manual; 2004. San Diego: University of California. Retrieved March 5 2007, from Scholar
  23. 23.
    Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychology Bulletin, 86(2), 420–428.CrossRefGoogle Scholar
  24. 24.
    Deyo, R. A., Diehr, P., & Patrick, D. L. (1991). Reproducibility and responsiveness of health status measures: Statistics and strategies for evaluation. Controlled Clinical Trials, 12(4), 142–158.CrossRefGoogle Scholar
  25. 25.
    Rosner, B. (2005). Fundamentals of biostatistics (6th ed.). Boston: Duxbury Press.Google Scholar
  26. 26.
    Stavem, K., Froland, S. S., & Hellum, K. B. (2005). Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Quality of Life Research, 14, 971–980. .PubMedCrossRefGoogle Scholar
  27. 27.
    Conner-Spady, B., & Suarez-Almazor, M. E. (2003). Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Medical Care, 41(7), 791–801.PubMedCrossRefGoogle Scholar
  28. 28.
    Longworth, L., Bryan, S. (2003). An empirical comparison of the EQ-5D and the SF-6D in liver transplant patients. Health Economics, 12, 1061–1067.PubMedCrossRefGoogle Scholar
  29. 29.
    Hahl, J., Hamalainen, H., Sintonen, H., Simell, T., Arinen, S., & Simell, O. (2002). Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Quality of Life Research, 11(5), 427–436.PubMedCrossRefGoogle Scholar
  30. 30.
    Feeny, D. H., Wu, L., & Eng, K. (2004). Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: Results from total hip arthroplasty patients. Quality of Life Research, 13(10), 1659–1670.PubMedCrossRefGoogle Scholar
  31. 31.
    Pickard, A. S., Johnson, J. A, & Feeny, D. H. (2005). Responsiveness of generic health-related quality-of-life measures in stroke. Quality of Life Research, 14, 207–219.PubMedCrossRefGoogle Scholar
  32. 32.
    Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). Comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13, 873–884.PubMedCrossRefGoogle Scholar
  33. 33.
    Grootendorst, P., Feeny, D., & Furlong, W. (2000). Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Medical Care, 38(3), 290–299.PubMedCrossRefGoogle Scholar
  34. 34.
    Stavem, K. (1999). Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Quality of Life Research, 8(1–2), 45–54.PubMedCrossRefGoogle Scholar
  35. 35.
    Marra, C. A., Rashidi, A. A., Guh, D., Kopec, J. A., Abrahamowicz, M., Esdaile, J. M., Brazier, J. E., Fortin, P. R., & Anis, A. H. (2005). Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Quality of Life Research, 14(5), 1333–1344.PubMedCrossRefGoogle Scholar
  36. 36.
    Hatoum, H. T., Brazier, J. E., & Akhras, K. S. (2004). Comparison of the HUI 3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health, 7(5), 602–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.University of GreifswaldInstitute for Community MedicineGreifswaldGermany

Personalised recommendations